Remdesivir drug trial, see table 2; "A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics:...what does it show? it shows more deaths (53.1%) than comparators
by Paul Alexander
Remdesivir failed for ebola, it was a failed dangerous drug, & the NIH study showed this as well as the LANCET Wang study that was dropped early the same NIH study; it causes liver and kidney toxicity
SOURCE:
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
See table 2
SOURCE:
Wang et al: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Key statement:
“In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits.”